Two River Group Holdings is a New York based venture capital firm that is focus on the formation of new companies that will acquire the rights to commerically develop pharmaceuticals, medical, therapeutics, diagnostic, and other healthcare related products.
About Two River Group
Two River Group Holdings is a New York based venture capital firm that is focus on the formation of new companies that will acquire the rights to commerically develop pharmaceuticals, medical, therapeutics, diagnostic, and other healthcare related products.Two River Group Holdings is a New York based venture capital firm that is focus on the formation of new companies that will acquire the rights to commerically develop pharmaceuticals, medical, therapeutics, diagnostic, and other healthcare related products.Two River Group Holdings is a New York based venture capital firm that is focus on the formation of new companies that will acquire the rights to commerically develop pharmaceuticals, medical, therapeutics, diagnostic, and other healthcare related products.Two River Group Holdings is a New York based venture capital firm that is focus on the formation of new companies that will acquire the rights to commerically develop pharmaceuticals, medical, therapeutics, diagnostic, and other healthcare related products.Two River Group Holdings is a New York based venture capital firm that is focus on the formation of new companies that will acquire the rights to commerically develop pharmaceuticals, medical, therapeutics, diagnostic, and other healthcare related products.Two River Group Holdings is a New York based venture capital firm that is focus on the formation of new companies that will acquire the rights to commerically develop pharmaceuticals, medical, therapeutics, diagnostic, and other healthcare related products.
Two River Group Holdings is a New York based venture capital firm that is focus on the formation of new companies that will acquire the rights to commerically develop pharmaceuticals, medical, therapeutics, diagnostic, and other healthcare related products. Two River Group Holdings is a New York based venture capital firm that is focus on the formation of new companies that will acquire the rights to commerically develop pharmaceuticals, medical, therapeutics, diagnostic, and other healthcare related products.
Paul B. Bolno, M.D., Director of Research

Dr. Bolno is currently the Director of Research at Two River Group. He was a resident in General Surgery at the University of Massachusetts and Hahnemann University Hospital. He completed his Post Doctoral Research Fellowship in Cardiothoracic Surgery at Drexel University. His research focused on directing stem cells for cardiac repair as well as other modalities for treating heart failure including cardiac assist devices.

Dr. Bolno's research has been presented at numerous national and international meetings. Dr. Bolno received his B.A. from Emory University and M.D. from Hahnemann University School of Medicine.

In addition he received his M.B.A from Drexel University with a concentration in Health Care/Biotechnology.


Two River Group Holdings is a New York based venture capital firm that is focus on the formation of new companies that will acquire the rights to commerically develop pharmaceuticals, medical, therapeutics, diagnostic, and other healthcare related products.		 Two River Group Holdings is a New York based venture capital firm that is focus on the formation of new companies that will acquire the rights to commerically develop pharmaceuticals, medical, therapeutics, diagnostic, and other healthcare related products.
Two River Group Holdings is a New York based venture capital firm that is focus on the formation of new companies that will acquire the rights to commerically develop pharmaceuticals, medical, therapeutics, diagnostic, and other healthcare related products.
© 2008 Two River Group Holdings, LLC | Terms of Use | Privacy Policy
Two River Group Holdings is a New York based venture capital firm that is focus on the formation of new companies that will acquire the rights to commerically develop pharmaceuticals, medical, therapeutics, diagnostic, and other healthcare related products.